This is a observational、multicenter, prospective cohort study for patients with pulmonary hypertension (PH). The purposes of this study were to evaluate the etiology、clinical characteristics、treatment modalities, and outcomes of patients with PH；also to set up registration system of PH in China, to build a database of Chinese PH, to establish a web-based international standard data acquisition system for PH and a multicenter clinical research platform. The results of the study will provide a basis for the future national health policy for prevention and treatment of PH.
Study Type
OBSERVATIONAL
Enrollment
1,000
The clinical course and disease management of pulmonary hypertension patients
Guangdong Provincial Peoples Hospital
Guangzhou, Guangdong, China
RECRUITINGNanjing First Hospital
Nanjing, Jiangsu, China
RECRUITINGGeneral Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, China
RECRUITINGBeijing Anzhen Hospital of Capital Medical University
Beijing, China
RECRUITINGChina-japan Friendship Hospital
Beijing, China
RECRUITINGXiangya Second Hospital, Central South University
Changsha, China
RECRUITINGWest China Hospital, Sichuan University
Chendu, China
RECRUITINGNanjing Drum Tower Hospital
Nanjing, China
RECRUITINGGeneral Hospital of Northen Theater of Command
Shenyang, China
RECRUITINGTongji Hospital, Huazhong University of Science and Technology
Wuhan, China
RECRUITING...and 3 more locations
All-cause Death
Time frame: 5 years
Number of Participants with Clinical Worsening
Clinical worsening during follow-up was defined as worsening PAH or atrial septostomy or listing for lung transplantation or all-cause death. Worsening PAH required the presence of worsening PAH symptoms and a decrease in 6-minute walk distance greater than 15% from baseline and the requirement for additional PAH treatments (all three conditions had to be present).
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.